CNS Disorders  >>  methylprednisolone sodium succinate  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylprednisolone sodium succinate / Generic mfg.
NCT01049451: Pulse ACTH vs. MP for MS

Completed
1
23
US
ACTH, Acthar Gel, Methylprednisolone, Solumedrol
University of Southern California
Multiple Sclerosis
06/13
07/13
A1AT for NMO, NCT02087813: Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses

Withdrawn
1
0
US
Alpha1-antitrypsin, ARALAST NP, alpha1-proteinase inhibitor, methylprednisolone, Solu-Medrol
Stanford University
Neuromyelitis Optica
03/16
 
NCT03605238: Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20

Withdrawn
1
0
RoW
Corticosteroids & tanCART19/20
Chinese PLA General Hospital
Neuromyelitis Optica Spectrum Disorder
08/19
08/20
NCT04227470: A Study of HBM9161 in NMOSD Patients

Completed
1
9
RoW
HBM9161 Injection
Harbour BioMed (Guangzhou) Co. Ltd.
NMO Spectrum Disorder
12/21
12/21

Download Options